Clinical Trial Update: The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial results on the usability and injection time of the Physiolis Syringe and Autoinjector in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Physiolis Syringe and Autoinjector

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2014-03-10